1. Angiolillo DJ. The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: From aspirin to the present day Drugs 2012;72:2087-116.
4. Costa F, Vanklaveren D, James S,et al. Derivation and validation of the predicting complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRICISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 2017;389: 1025-34.
5.
5. Philippe Généreux, Gennaro Giustino, Bernhard Witzenbichler và các cộng sự. (2015), “Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention”, Journal of the American College of Cardiology, 66(9), tr. 1036-1045.
6. Thomas W. Weiss et al. Expert position paper on prolongged dual antiplatelet therapy in secondary prevention following myocardial infarction. Wien klin Wochenschr 2016;128:450-457. DOI 10.1007/ s00508-016-1016-7.
7.
7. Laura Mauri, Dean J Kereiakes, Robert W Yeh và các cộng sự. (2014), “Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents”, New England Journal of Medicine, 371(23), tr. 2155-2166.
8. Marco Valgimigli, Héctor Bueno, Robert A Byrne và các cộng sự. (2017), “2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS”, European journal of cardio-thoracic surgery, 53(1), tr. 34-78
Tác giả
Nguyễn Thị Thanh: Bệnh viện Đa khoa tỉnh Thanh Hoá;
Nguyễn Ngọc Quang: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;